A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies - BeOne

A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies

Ask to Join

BeOne Study ID

BGB-21447-101

ClinicalTrials.gov ID

NCT05828589

EudraCT Number

2025-521600-21-00

China Drug Trials ID

CTR20231287

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents

Locations

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents